A Real‐World Study of CGRP Monoclonal Antibodies for Migraine: Long‐Term Effectiveness and Treatment Adherence

Key Points

• This research aims to evaluate the long-term effectiveness and treatment adherence of CGRP monoclonal antibodies for migraine.
• Real-world observational study design
• Assessment of migraine frequency over time
• Evaluation of adverse effects and patient tolerability
• CGRP monoclonal antibodies significantly reduced migraine frequency over the long term
• Patients reported favorable tolerability throughout the treatment period